Immunotherapy Responsive Recurrent Post-Infectious Ataxia Associated With Recurrent ATP2B2 Gene Variant

Jenae Vancura1, Abhik K Banerjee2, Natalie K Boyd2

  • 1Keck School of Medicine of the University of Southern California, Los Angeles.

Neurology. Genetics
|January 21, 2025
PubMed
Summary

This case study highlights recurrent cerebellar ataxia in a child, linked to an ATP2B2 gene variant. Intravenous immunoglobulin (IVIg) therapy showed significant improvement, suggesting a potential treatment avenue.